Illumina

Sr Field Service Partner

South Africa

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, Healthcare EquipmentIndustries

Requirements

Candidates should possess a Bachelor’s degree in Electrical/Electronics Engineering, Mechanical Engineering, or a related degree/diploma, with knowledge in the biotechnology/biomedical industry, and a minimum of 5 years of relevant experience. Strong problem-solving (troubleshooting) abilities, excellent verbal and written communication skills, and good technical writing abilities are required, along with computer experience and literacy. Familiarity with field optical alignments, robotics, electrical/electronics, and mechanical systems is also necessary.

Responsibilities

The Senior Field Service Engineer – South Africa will be responsible for direction and coordination of service-related activities of Illumina products in Africa, including installation, repair, preventative maintenance, and engineering change upgrades. They will assist with interfacing between the field organization and internal support structure, serve as a focal point for problem resolution assistance, edit and modify service manuals, install and upgrade instrument systems, provide technical support to staff and customers, manage service parts inventory, maintain customer information and databases, and respond to service requests while ensuring customer satisfaction. Additionally, the incumbent will travel approximately 60-70% of the time, working in conjunction with other staff to coordinate new system placements, promote upgrades and contract renewals, and maintain routine contact with the existing customer base.

Skills

Instrument installation
Repair
Preventive maintenance
Engineering change upgrades
Troubleshooting
Technical support
Manual editing
Customer service

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI